$PCRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Pacira BioSciences, Inc.. Get notifications about new insider transactions in Pacira BioSciences, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President, Rest of ... | Option Exercise | A | 60.96 | 17,500 | 1,066,800 | 17,500 | |
Jun 11 2021 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President, Rest of ... | Grant | A | 0.00 | 7,000 | 0 | 17,500 | 10.5 K to 17.5 K (+66.67 %) |
Jun 11 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 60.96 | 6,500 | 396,240 | 6,500 | |
Jun 11 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 59.85 | 2,003 | 119,880 | 12,731 | 14.7 K to 12.7 K (-13.59 %) |
Jun 11 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 2,600 | 0 | 14,734 | 12.1 K to 14.7 K (+21.43 %) |
Jun 11 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Option Exercise | A | 60.96 | 17,500 | 1,066,800 | 17,500 | |
Jun 11 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Grant | A | 0.00 | 7,000 | 0 | 31,035 | 24 K to 31 K (+29.12 %) |
Jun 11 2021 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Option Exercise | A | 60.96 | 7,626 | 464,881 | 7,626 | |
Jun 11 2021 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,066 | 0 | 16,737 | 15.7 K to 16.7 K (+6.80 %) |
Jun 11 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | A | 60.96 | 7,626 | 464,881 | 7,626 | |
Jun 11 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,066 | 0 | 6,552 | 5.5 K to 6.6 K (+19.43 %) |
Jun 11 2021 | PCRX | Pacira BioSciences ... | CHRISTIE CHRISTOPHER | Director | Option Exercise | A | 60.96 | 7,626 | 464,881 | 7,626 | |
Jun 11 2021 | PCRX | Pacira BioSciences ... | CHRISTIE CHRISTOPHER | Director | Grant | A | 0.00 | 1,066 | 0 | 2,326 | 1.3 K to 2.3 K (+84.60 %) |
Jun 08 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 61.04 | 14,905 | 909,756 | 61,156 | 76.1 K to 61.2 K (-19.60 %) |
May 13 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 10.81 | 21,250 | 229,713 | 88,670 | |
May 13 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 10.81 | 21,250 | 229,713 | 109,920 | |
May 13 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 62.41 | 3,611 | 225,363 | 76,061 | 79.7 K to 76.1 K (-4.53 %) |
May 13 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 62.08 | 14,669 | 910,652 | 79,672 | 94.3 K to 79.7 K (-15.55 %) |
May 13 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 60.76 | 2,970 | 180,457 | 94,341 | 97.3 K to 94.3 K (-3.05 %) |
May 13 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 10.81 | 21,250 | 229,713 | 97,311 | 76.1 K to 97.3 K (+27.94 %) |
May 13 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 61.19 | 7,932 | 485,359 | 76,061 | 84 K to 76.1 K (-9.44 %) |
May 13 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 60.78 | 13,318 | 809,468 | 83,993 | 97.3 K to 84 K (-13.69 %) |
May 13 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 10.81 | 21,250 | 229,713 | 97,311 | 76.1 K to 97.3 K (+27.94 %) |
May 13 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Gift | G | 0.00 | 1,080 | 0 | 97,273 | 98.4 K to 97.3 K (-1.10 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 43.54 | 6,339 | 276,000 | 19,010 | |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 38.35 | 8,859 | 339,743 | 14,765 | |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 44.20 | 4,125 | 182,325 | 1,375 | |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 32.35 | 2,500 | 80,875 | 0 | |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 68.11 | 7,030 | 478,813 | 24,887 | 31.9 K to 24.9 K (-22.03 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 66.40 | 14,793 | 982,255 | 31,917 | 46.7 K to 31.9 K (-31.67 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 43.54 | 6,339 | 276,000 | 46,710 | 40.4 K to 46.7 K (+15.70 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 38.35 | 8,859 | 339,743 | 40,371 | 31.5 K to 40.4 K (+28.11 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 44.20 | 4,125 | 182,325 | 31,512 | 27.4 K to 31.5 K (+15.06 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 32.35 | 2,500 | 80,875 | 27,387 | 24.9 K to 27.4 K (+10.05 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 43.54 | 6,339 | 276,000 | 19,010 | |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 38.35 | 8,859 | 339,743 | 14,765 | |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 44.20 | 4,125 | 182,325 | 1,375 | |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 32.35 | 2,500 | 80,875 | 0 | |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 68.11 | 7,030 | 478,813 | 24,887 | 31.9 K to 24.9 K (-22.03 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 66.40 | 14,793 | 982,255 | 31,917 | 46.7 K to 31.9 K (-31.67 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 43.54 | 6,339 | 276,000 | 46,710 | 40.4 K to 46.7 K (+15.70 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 38.35 | 8,859 | 339,743 | 40,371 | 31.5 K to 40.4 K (+28.11 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 44.20 | 4,125 | 182,325 | 31,512 | 27.4 K to 31.5 K (+15.06 %) |
Apr 15 2021 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 32.35 | 2,500 | 80,875 | 27,387 | 24.9 K to 27.4 K (+10.05 %) |
Apr 02 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Option Exercise | M | 34.38 | 13,750 | 472,656 | 6,250 | |
Apr 02 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Sell | S | 72.12 | 1,200 | 86,544 | 26,311 | 27.5 K to 26.3 K (-4.36 %) |
Apr 02 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Sell | S | 71.09 | 4,661 | 331,350 | 27,511 | 32.2 K to 27.5 K (-14.49 %) |
Apr 02 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Sell | S | 70.36 | 16,363 | 1,151,301 | 32,172 | 48.5 K to 32.2 K (-33.71 %) |
Apr 02 2021 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Buy | M | 34.38 | 13,750 | 472,656 | 48,535 | 34.8 K to 48.5 K (+39.53 %) |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 2,000 | 21,620 | 14,300 | |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 1,520 | 16,431 | 16,300 | |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 70.01 | 2,000 | 140,020 | 13,181 | 15.2 K to 13.2 K (-13.17 %) |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 2,000 | 21,620 | 15,181 | 13.2 K to 15.2 K (+15.17 %) |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 73.28 | 1,520 | 111,386 | 13,181 | 14.7 K to 13.2 K (-10.34 %) |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 1,520 | 16,431 | 14,701 | 13.2 K to 14.7 K (+11.53 %) |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Froimson Mark | Director | Sell | S | 72.26 | 734 | 53,039 | 5,242 | 6 K to 5.2 K (-12.28 %) |
Mar 16 2021 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 73.68 | 10,601 | 781,082 | 451,324 | 461.9 K to 451.3 K (-2.29 %) |
Mar 16 2021 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 73.10 | 58,754 | 4,294,917 | 461,925 | 520.7 K to 461.9 K (-11.28 %) |
Mar 11 2021 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 72.70 | 60,574 | 4,403,730 | 520,679 | 581.3 K to 520.7 K (-10.42 %) |
Mar 11 2021 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 71.78 | 76,480 | 5,489,734 | 581,253 | 657.7 K to 581.3 K (-11.63 %) |
Mar 11 2021 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 70.90 | 35,137 | 2,491,213 | 657,733 | 692.9 K to 657.7 K (-5.07 %) |
Mar 09 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | M | 13.98 | 3,000 | 41,940 | 0 | |
Mar 09 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Sell | S | 65.88 | 3,000 | 197,640 | 6,116 | 9.1 K to 6.1 K (-32.91 %) |
Mar 09 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Buy | M | 13.98 | 3,000 | 41,940 | 9,116 | 6.1 K to 9.1 K (+49.05 %) |
Feb 04 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 10.81 | 21,250 | 229,713 | 131,170 | |
Feb 04 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 10.81 | 21,250 | 229,713 | 152,420 | |
Feb 04 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 71.42 | 14,350 | 1,024,877 | 76,061 | 90.4 K to 76.1 K (-15.87 %) |
Feb 04 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 70.78 | 6,900 | 488,382 | 90,411 | 97.3 K to 90.4 K (-7.09 %) |
Feb 04 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 10.81 | 21,250 | 229,713 | 97,311 | 76.1 K to 97.3 K (+27.94 %) |
Feb 04 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 70.20 | 4,100 | 287,820 | 76,061 | 80.2 K to 76.1 K (-5.11 %) |
Feb 04 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 69.38 | 14,250 | 988,665 | 80,161 | 94.4 K to 80.2 K (-15.09 %) |
Feb 04 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 68.41 | 2,900 | 198,389 | 94,411 | 97.3 K to 94.4 K (-2.98 %) |
Feb 04 2021 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 10.81 | 21,250 | 229,713 | 97,311 | 76.1 K to 97.3 K (+27.94 %) |
Jan 08 2021 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Sell | S | 60.81 | 110 | 6,689 | 14,000 | 14.1 K to 14 K (-0.78 %) |
Jan 08 2021 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Sell | S | 60.81 | 110 | 6,689 | 14,000 | 14.1 K to 14 K (-0.78 %) |
Nov 17 2020 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Sell | S | 62.00 | 5,000 | 310,000 | 34,785 | 39.8 K to 34.8 K (-12.57 %) |
Sep 29 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 16.67 | 70,000 | 1,166,900 | 0 | |
Sep 29 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 16.67 | 70,000 | 1,166,900 | 129,949 | 59.9 K to 129.9 K (+116.77 %) |
Sep 21 2020 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Option Exercise | M | 42.54 | 25,000 | 1,063,500 | 175,000 | |
Sep 21 2020 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Sell | S | 60.26 | 2,888 | 174,031 | 14,000 | 16.9 K to 14 K (-17.10 %) |
Sep 21 2020 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Sell | S | 59.75 | 22,532 | 1,346,287 | 16,888 | 39.4 K to 16.9 K (-57.16 %) |
Sep 21 2020 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Buy | M | 42.54 | 25,000 | 1,063,500 | 39,000 | 14 K to 39 K (+178.57 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 43.54 | 2,819 | 122,739 | 25,349 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 38.35 | 7,878 | 302,121 | 23,624 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 44.20 | 5,502 | 243,188 | 5,500 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 32.35 | 5,836 | 188,795 | 2,500 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 40.34 | 5,836 | 235,424 | 0 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 43.54 | 2,816 | 122,609 | 28,168 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 38.35 | 7,874 | 301,968 | 31,502 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 44.20 | 5,499 | 243,056 | 11,002 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 32.35 | 5,832 | 188,665 | 8,336 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 40.34 | 5,832 | 235,263 | 5,836 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 43.54 | 2,816 | 122,609 | 30,984 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 38.35 | 7,874 | 301,968 | 39,376 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 44.20 | 5,499 | 243,056 | 16,501 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 32.35 | 5,832 | 188,665 | 14,168 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | M | 40.34 | 5,832 | 235,263 | 11,668 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 60.22 | 3,200 | 192,704 | 24,887 | 28.1 K to 24.9 K (-11.39 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 59.77 | 24,671 | 1,474,586 | 28,087 | 52.8 K to 28.1 K (-46.76 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 43.54 | 2,819 | 122,739 | 52,758 | 49.9 K to 52.8 K (+5.64 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 38.35 | 7,878 | 302,121 | 49,939 | 42.1 K to 49.9 K (+18.73 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 44.20 | 5,502 | 243,188 | 42,061 | 36.6 K to 42.1 K (+15.05 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 32.35 | 5,836 | 188,795 | 36,559 | 30.7 K to 36.6 K (+19.00 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 40.34 | 5,836 | 235,424 | 30,723 | 24.9 K to 30.7 K (+23.45 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 60.33 | 21,244 | 1,281,651 | 24,887 | 46.1 K to 24.9 K (-46.05 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 59.54 | 6,609 | 393,500 | 46,131 | 52.7 K to 46.1 K (-12.53 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 43.54 | 2,816 | 122,609 | 52,740 | 49.9 K to 52.7 K (+5.64 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 38.35 | 7,874 | 301,968 | 49,924 | 42.1 K to 49.9 K (+18.73 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 44.20 | 5,499 | 243,056 | 42,050 | 36.6 K to 42.1 K (+15.04 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 32.35 | 5,832 | 188,665 | 36,551 | 30.7 K to 36.6 K (+18.98 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 40.34 | 5,832 | 235,263 | 30,719 | 24.9 K to 30.7 K (+23.43 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 59.80 | 13,231 | 791,214 | 24,887 | 38.1 K to 24.9 K (-34.71 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 59.01 | 14,622 | 862,844 | 38,118 | 52.7 K to 38.1 K (-27.72 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 43.54 | 2,816 | 122,609 | 52,740 | 49.9 K to 52.7 K (+5.64 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 38.35 | 7,874 | 301,968 | 49,924 | 42.1 K to 49.9 K (+18.73 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 44.20 | 5,499 | 243,056 | 42,050 | 36.6 K to 42.1 K (+15.04 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 32.35 | 5,832 | 188,665 | 36,551 | 30.7 K to 36.6 K (+18.98 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Buy | M | 40.34 | 5,832 | 235,263 | 30,719 | 24.9 K to 30.7 K (+23.43 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 3,000 | 32,430 | 20,820 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 60.34 | 3,000 | 181,020 | 13,181 | 16.2 K to 13.2 K (-18.54 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 3,000 | 32,430 | 16,181 | 13.2 K to 16.2 K (+22.76 %) |
Sep 11 2020 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 62.02 | 2,216 | 137,436 | 692,970 | 695.2 K to 693 K (-0.32 %) |
Sep 11 2020 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 62.02 | 2,216 | 137,436 | 692,970 | 695.2 K to 693 K (-0.32 %) |
Aug 19 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 62.34 | 3,217 | 200,548 | 173,377 | 176.6 K to 173.4 K (-1.82 %) |
Aug 19 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 61.79 | 11,783 | 728,072 | 176,594 | 188.4 K to 176.6 K (-6.26 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 61.47 | 34,904 | 2,145,549 | 695,186 | 730.1 K to 695.2 K (-4.78 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 60.82 | 113,500 | 6,903,070 | 730,090 | 843.6 K to 730.1 K (-13.45 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 61.90 | 46,151 | 2,856,747 | 843,590 | 889.7 K to 843.6 K (-5.19 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 60.87 | 60,621 | 3,690,000 | 889,741 | 950.4 K to 889.7 K (-6.38 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 61.47 | 34,904 | 2,145,549 | 695,186 | 730.1 K to 695.2 K (-4.78 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 60.82 | 113,500 | 6,903,070 | 730,090 | 843.6 K to 730.1 K (-13.45 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 61.90 | 46,151 | 2,856,747 | 843,590 | 889.7 K to 843.6 K (-5.19 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Wicki Andreas | Director | Sell | S | 60.87 | 60,621 | 3,690,000 | 889,741 | 950.4 K to 889.7 K (-6.38 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 8,180 | 84,581 | 0 | |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 60.50 | 8,180 | 494,890 | 13,181 | 21.4 K to 13.2 K (-38.29 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 8,180 | 84,581 | 20,813 | 12.6 K to 20.8 K (+64.75 %) |
Aug 05 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | M | 44.10 | 2,500 | 110,250 | 7,500 | |
Aug 05 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Sell | S | 52.68 | 2,500 | 131,700 | 20,796 | 23.3 K to 20.8 K (-10.73 %) |
Aug 05 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Buy | M | 44.10 | 2,500 | 110,250 | 22,750 | 20.3 K to 22.8 K (+12.35 %) |
Jul 17 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 56.88 | 12,000 | 682,560 | 188,377 | 200.4 K to 188.4 K (-5.99 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 6,000 | 62,040 | 8,180 | |
Jul 01 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 50.34 | 2,000 | 100,680 | 12,633 | 14.6 K to 12.6 K (-13.67 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 49.34 | 2,000 | 98,680 | 14,633 | 16.6 K to 14.6 K (-12.02 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 48.72 | 2,000 | 97,440 | 16,633 | 18.6 K to 16.6 K (-10.73 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 6,000 | 62,040 | 18,633 | 12.6 K to 18.6 K (+47.49 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | M | 44.10 | 30,000 | 1,323,000 | 10,000 | |
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | M | 43.54 | 7,500 | 326,550 | 22,500 | |
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | M | 38.35 | 15,000 | 575,250 | 15,000 | |
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | M | 37.81 | 3,750 | 141,788 | 6,250 | |
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Sell | S | 52.03 | 1,778 | 92,509 | 20,250 | 22 K to 20.3 K (-8.07 %) |